Status: Recruiting
A Phase 2a Study of SUN-627 in Participants With Non-Active Secondary Progressive and Primary Progressive Multiple Sclerosis (SPMS/PPMS)
The goal of this Phase 2 clinical trial is to investigate the safety and tolerability of SUN-627 in men and women aged 18-70 years old with a diagnosis of non-active SPMS/PPMS.
Participants needed: 20
Trial details
Phase: Phase 2Age: 18-70Biological sex: AllType: InterventionalSponsor: Sundance Biosciences, Inc.Updated: Sep 25, 2026Locations: 3
Eligibility criteria
Aged 18-70, inclusive [+4]
Use of certain medications or treatments before the study, or need for these tre... [+4]